Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-20 Sale | 2024-11-21 4:04 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial | 19,388 | $16.87 | $327,085 | 234,580 (Direct) | View |
| 2024-08-12 Sale | 2024-08-13 4:09 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 98,943 | $17.3 | $1,711,447 | 0 (Direct) | View |
| 2024-08-09 Sale | 2024-08-13 4:06 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Grant Angus EVP, Business Development | 4,065 | $17.28 | $70,243 | 47,587 (Direct) | View |
| 2024-08-09 Sale | 2024-08-13 4:02 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 45,060 | $17.38 | $782,972 | 0 (Direct) | View |
| 2024-08-01 Sale | 2024-08-05 07:35 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 24,537 | $17.25 | $423,280 | 150,546 (Direct) | View |
| 2024-06-18 Sale | 2024-06-21 4:05 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | MIGNONE ROBERTO Director | 519,000 | $17.03 | $8,838,570 | 1,076,683 (Indirect Direct) | View |
| 2024-05-15 Sale | 2024-05-17 07:41 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 28,135 | $16.73 | $470,794 | 5,179 (Direct) | View |
| 2024-05-13 Sale | 2024-05-15 08:36 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Conway Vikki L See "Remarks" | 15,219 | $16.74 | $254,807 | 0 (Direct) | View |
| 2024-03-06 Sale | 2024-03-07 4:27 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 77,550 | $13.52 | $1,048,119 | 225,081 (Direct) | View |
| 2024-03-05 Sale | 2024-03-07 4:20 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 48,629 | $13.52 | $657,240 | 121,519 (Direct) | View |
| 2024-03-05 Sale | 2024-03-07 4:16 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Conway Vikki L See "Remarks" | 1,427 | $13.52 | $19,286 | 20,176 (Direct) | View |
| 2024-03-05 Sale | 2024-03-07 4:12 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets | 100,000 | $13.52 | $1,352,090 | 406,355 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-20 Exercise | 2024-11-21 4:04 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial | 63,492 | $0 | 234,580 (Direct) | View |
| 2024-09-02 Exercise | 2024-09-04 07:40 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shalev Varda Director | 12,872 | $0 | 12,872 (Direct) | View |
| 2024-08-09 Exercise | 2024-08-13 4:06 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Grant Angus EVP, Business Development | 12,913 | $0 | 47,587 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-05 07:35 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 52,742 | $0 | 150,546 (Direct) | View |
| 2024-08-01 Option Award | 2024-08-05 07:32 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Jover Placid See "Remarks" | 51,311 | $0 | 51,311 (Direct) | View |
| 2024-06-15 Exercise | 2024-06-17 08:03 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Zaks Tal Zvi Director | 21,108 | $0 | 49,140 (Direct) | View |
| 2024-06-15 Exercise | 2024-06-17 08:00 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | MIGNONE ROBERTO Director | 21,108 | $0 | 3,095,683 (Direct) | View |
| 2024-06-15 Exercise | 2024-06-17 07:41 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Crane Rosemary A Director | 21,108 | $0 | 103,615 (Direct) | View |
| 2024-06-15 Exercise | 2024-06-17 07:38 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Satchi-Fainaro Ronit Director | 21,108 | $0 | 88,277 (Direct) | View |
| 2024-06-15 Exercise | 2024-06-17 07:27 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nisen Perry Director | 21,108 | $0 | 95,683 (Direct) | View |
| 2024-06-15 Exercise | 2024-06-17 07:23 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Vergis Janet S. Director | 21,108 | $0 | 64,065 (Direct) | View |
| 2024-06-15 Exercise | 2024-06-17 07:20 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | LIEBERMAN GERALD M Director | 21,108 | $0 | 106,025 (Direct) | View |
| 2024-06-15 Exercise | 2024-06-17 07:17 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Elstein Amir Director | 21,108 | $0 | 2,094,331 (Direct) | View |
| 2024-06-15 Exercise | 2024-06-17 07:14 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | BARER SOL J Director | 37,598 | $0 | 409,114 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 07:53 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shalev Varda Director | 9,632 | $0 | 9,632 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 07:51 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Zaks Tal Zvi Director | 9,632 | $0 | 9,632 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 07:49 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Crane Rosemary A Director | 9,632 | $0 | 9,632 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 07:47 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Satchi-Fainaro Ronit Director | 9,632 | $0 | 9,632 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 07:45 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | MIGNONE ROBERTO Director | 9,632 | $0 | 9,632 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 07:42 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nisen Perry Director | 9,632 | $0 | 9,632 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 07:38 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | LIEBERMAN GERALD M Director | 9,632 | $0 | 9,632 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 07:36 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Vergis Janet S. Director | 9,632 | $0 | 9,632 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 07:33 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Elstein Amir Director | 9,632 | $0 | 9,632 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 07:31 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | BARER SOL J Director | 17,158 | $0 | 17,158 (Direct) | View |
| 2024-06-03 Option Award | 2024-06-05 07:25 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shields Matthew EVP, Global Operations | 64,782 | $0 | 64,782 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-07 4:27 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 73,707 | $0 | 225,081 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-07 4:24 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations | 77,802 | $0 | 168,491 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-07 4:20 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 77,802 | $0 | 121,519 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-07 4:16 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Conway Vikki L See "Remarks" | 4,954 | $0 | 20,176 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-07 4:12 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets | 81,897 | $0 | 406,355 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-07 4:08 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 3,564 | $0 | 36,880 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-05 4:46 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | McAvoy David R. EVP, Chief Legal Officer | 66,964 | $0 | 66,964 (Direct) | View |